oral estradiol 1.0 mg + oral progesterone 100 mg
Phase 3Completed 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Menopause
Conditions
Menopause
Trial Timeline
Dec 1, 2015 → Aug 1, 2018
NCT ID
NCT02224313About oral estradiol 1.0 mg + oral progesterone 100 mg
oral estradiol 1.0 mg + oral progesterone 100 mg is a phase 3 stage product being developed by TherapeuticsMD for Menopause. The current trial status is completed. This product is registered under clinical trial identifier NCT02224313. Target conditions include Menopause.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02224313 | Phase 3 | Completed |
Competing Products
20 competing products in Menopause